Last updated
Revenue
R&D Expenses
Operating CF
Total Assets
Total Liabilities
Equity
Shares Out.
D/E Ratio
Dilution Watch
Financials
52W LOW $2.7852W HIGH $5.79
Volume
46.73 K
Value Traded
244.27 K
Short % Float
3.96%
Days to Cover
3.9
-6.5%Week
-0.19%1 Month
+79.12%3 Month
+65.73%6 Month
Cash Data
- Monthly Burn
- Burn Trend
- Dilution Risk
- SEC Filing
Key Stats
Market Cap
542.00 M
EPS (TTM)
0.48
P/E Ratio
11.16
Ent. Value
398.99 M
Total Shares
102.85 M
Float Shares
18.97 M
Insiders
81.55%
Institutions
4.26%
Upcoming Catalysts
FDA decisions, readouts and PDUFA dates · scored by probability of approval
| Catalyst | Drug / Treatment | Stage | Prob. of Approval | Description | Drug Type | Therapeutic Area | Source |
|---|
PoA blends historical approval base rates, trial design score and FDA review track record.
SBC Catalyst Timeline
Dated clinical, regulatory and corporate events for SBC Medical Group Holdings Incorporated
Past FDA Catalysts and PDUFA Decisions
How SBC actually traded into and out of each decision
| Date | Drug | Catalyst | Stage | Reaction | Event Move % | Best Trade % |
|---|---|---|---|---|---|---|
| No matching catalysts | ||||||
Reaction: 30 trading days around the event · Event Move: close to close on decision day · Best Trade: peak run-up from entry 10 days before the decision
Drug Pipeline Intelligence
Clinical Trial Results
Readouts, endpoints and source filings for every SBC program
| Drug Name | Indication | Phase | Date | Trial Results Summary | Title | Source |
|---|
Inside Trades
| Insider | Side | Shares | Price | Value | Date |
|---|---|---|---|---|---|
| Aikawa YoshiyukiDirector, Officer (Chairman and CEO), 10% Owner | Sell | -465,000 78,839,460 held | $3.02 | 04/28/2026 |
Hedge Fund 13F Activity
Hedge Funds invested in SBC
| Fund | % of Portfolio | Current MV | Shares Owned | Activity |
|---|---|---|---|---|
| No hedge fund reported a 13F position in SBC for Q2 2026. | ||||
Ownership Trends
SBC Short Interest
Shares sold short, counted twice a month.
3.96%
Short % of Float
of tradable shares sold short
750.8K
Shares Sold Short
-7.8% vs prior count
3.9 Moderate
Days to Cover
trading days of normal volume to buy every short share back
192.2K
Avg Daily Volume
the average used for days to cover
Options Data
Option Volume
Open Interest
Call OI
Put OI
Put-Call Ratio
OI 30-day avg
Today vs avg
Option Volume
Call Vol
Put Vol
Put-Call Ratio
Vol 30-day avg
Today vs avg
Option Chain Statistics
| Expiry | Call Vol | Put Vol | Vol P/C | Call OI | Put OI | OI P/C | IV Call | IV Call OI-Wtd | IV Call Vol-Wtd | IV Put | IV Put OI-Wtd | IV Put Vol-Wtd |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026-11-20 | ||||||||||||
Real-Time Option Chain
| Calls | Strike | Puts | ||||
|---|---|---|---|---|---|---|
| Last | Vol | OI | Last | Vol | OI | |
| No data available | ||||||
Calls vs Puts by Expiry
CallsPutsLog scale
Competitive positioning
How SBC ranks across every disease it competes in
Competitive Position is a premium feature
See how SBC ranks against every competitor across each disease it develops in: phase, best drug, trials and likelihood of approval.
Start free trialSBC News
-SBC
Nov 5, 2026▼ -0.9%today
Shonan Beauty Clinic Named to Newsweek’s “World’s Best Hospitals & Clinics for Medical Tourism 2027”
SBC Medical Group Holdings announced that Shonan Beauty Clinic has been recognized in Newsweek's 'World's Best Hospitals & Clinics for Medical Tourism 2027.' This accolade highlights the clinic's excellence in medical tourism, supported by the company's management services.
Read more →-SBC
Nov 3, 2026▼ -0.9%today
SBC Medical to Announce 3Q 2026 Financial Results
SBC Medical Group Holdings will release its Q3 2026 financial results on November 13, 2026, before market open. An earnings conference call will follow at 8:30 a.m. ET, allowing for a Q&A session with investors. The company continues to expand its services and enhance its reputation in the healthcare sector.
Read more →-SBC
Nov 2, 2026▼ -0.9%today
SBC Medical Forms Capital and Business Alliance with AtomicSoftware, Provider of the medicalforce Clinic Management Platform Used by 800+ Clinics in Japan
SBC Medical Group Holdings announced a capital and business alliance with AtomicSoftware on October 26, 2026. This partnership aims to leverage AtomicSoftware's medicalforce platform, which is utilized by more than 800 clinics in Japan. The collaboration is expected to enhance management support across various healthcare fields.
Read more →-SBC
Oct 22, 2026SBC Medical Initiates Development of a DNA Methylation Test to Estimate Biological Age
SBC Medical Group Holdings has begun developing a DNA methylation test to estimate biological age. This initiative will be managed by its subsidiary, SBC AI Longevity Innovation, Inc. The test aims to leverage advanced analysis techniques to provide insights into individual biological aging.
Read more →-SBC
Oct 12, 2026SBC Medical to Present at Cantor Fitzgerald Hong Kong’s Inaugural Asia Longevity Forum
SBC Medical Group Holdings announced that its CFO Yuya Yoshida will present at the inaugural Asia Longevity Forum hosted by Cantor Fitzgerald Hong Kong. The event will focus on the longevity economy and innovative healthcare solutions. Following the forum, SBC Medical will also conduct a non-deal roadshow in Hong Kong to engage with investors. This initiative reflects the company's commitment to advancing its presence in the longevity market.
Read more →-SBC
Sep 25, 2026SBC Medical to Participate in Several Upcoming Investor Conferences in October 2026
SBC Medical Group Holdings announced its participation in several investor conferences scheduled for October 2026. The company will engage with institutional investors through presentations and one-on-one meetings. This participation highlights SBC Medical's commitment to expanding its presence in the healthcare sector and fostering investor relations.
Read more →-SBC
Sep 1, 2026SBC Medical to Participate in Several Upcoming Investor Conferences in September 2026
SBC Medical is set to participate in several investor conferences and conduct a Non-Deal Roadshow in September 2026. This initiative aims to strengthen its relationships with investors and increase market visibility. The company's active engagement in these events reflects its commitment to growth and investor communication.
Read more →-SBC
Aug 13, 2026SBC Medical Group Holdings Reports Second Quarter 2026 Financial Results
SBC Medical Group Holdings has reported strong financial results for the second quarter of 2026. The company experienced a 13% increase in revenue compared to the previous year, alongside a remarkable 335% rise in net income. Additionally, adjusted EBITDA grew by 32%, reflecting a successful restructuring and reacceleration of growth.
Read more →-SBC
Aug 3, 2026SBC Medical to Announce 2Q 2026 Financial Results
SBC Medical Group Holdings Incorporated will announce its financial results for Q2 2026 on August 13, 2026. The announcement will precede a conference call at 8:30 a.m. ET, which will include a Q&A session for analysts and investors. The company continues to expand its operations and is recognized for its quality medical services.
Read more →-SBC
Jul 15, 2026SBC Medical to Participate in the “Health, Wellness & Longevity” Virtual Conference Presented by Maxim Group LLC on Wednesday, July 22nd at 10:30 a.m. ET
SBC Medical Group Holdings will present at the 'Health, Wellness & Longevity' virtual conference hosted by Maxim Group on July 22nd. Key executives will discuss consumer wellness trends and innovations in the healthcare sector. The event aims to address emerging consumer preferences and regulatory challenges in health-related markets.
Read more →-SBC
Jul 8, 2026SBC Medical Launches Japan's First Specialized Men's Beard Hair Removal Clinic, Introducing a Scalable, Capital-Efficient Growth Platform
SBC Medical Group Holdings has announced the opening of SBC MEN'S FLASH CLINIC in Ikebukuro, Tokyo, on August 6, 2026. This clinic is Japan's first dedicated to men's beard hair removal, aiming to capitalize on the growing demand for aesthetic services among men. The clinic features a standardized model designed for scalability and efficiency, enhancing customer acquisition and service delivery in the aesthetic healthcare market.
Read more →-SBC
Jul 2, 20262026 Annual Meeting
The article provides an overview of the 2026 Annual Meeting for SBC, detailing various aspects such as stock information, financial data, corporate governance, and investor relations. It highlights the structure of the meeting and the availability of resources for stakeholders. However, no specific details about the meeting's agenda or outcomes are mentioned.
Read more →-SBC
May 27, 20265 Virtual Conference After 1Q
The article discusses an upcoming virtual conference scheduled after the first quarter. It provides an overview of stock information, financial data, and corporate governance details. Additionally, it highlights the company's events and presentations, along with contact information for investor relations.
Read more →-SBC
May 27, 20262Q2026 Earnings Call
The article provides an overview of the 2Q2026 earnings call for SBC. It outlines various sections including stock information, financial data, corporate governance, and investor relations. However, specific financial results or insights from the earnings call are not detailed in the text.
Read more →-SBC
May 26, 2026Participation in several upcoming investor conferences in May and June 2026
SBC Medical Group Holdings Incorporated announced its participation in several investor conferences scheduled for May and June 2026. The company will deliver webcast presentations and hold one-on-one meetings with institutional investors. This engagement highlights SBC Medical's commitment to enhancing its visibility and expanding its global operations in various healthcare fields.
Read more →-SBC
May 26, 2026SBC Medical will participate in several upcoming investor conferences in May and June 2026
SBC Medical Group Holdings Incorporated announced its participation in several investor conferences in May and June 2026. The company will conduct webcast presentations and one-on-one meetings with institutional investors. SBC Medical continues to expand its global operations and was recently included in the Russell 3000 Index.
Read more →-SBC
May 22, 2026SBC Medical and BLEZ ASIA Celebrate Opening of New Aesthetic Dermatology Section at BLEZ CLINIC in Bangkok
SBC Medical Group Holdings has partnered with BLEZ ASIA to inaugurate a new aesthetic dermatology section at BLEZ CLINIC in Bangkok. This initiative aims to provide high-quality aesthetic healthcare services tailored to Japanese expatriates. The section will initially offer pico laser treatments and is set to launch in June 2026, with plans for future expansion across Thailand and ASEAN.
Read more →-SBC
May 14, 2026▼ -7.7%on this newsshared move
SBC Medical Group Holdings Announces First Quarter 2026 Financial Results
SBC Medical Group Holdings announced its financial results for the first quarter of 2026, revealing a revenue decline of 9% year-over-year to $43 million. Net income also saw a considerable drop by 47%, with earnings per share falling to $0.11. Despite these downturns, the company reported an increase in the number of franchise locations and a rise in customer count. Looking ahead, SBC Medical plans to enhance its services and expand its presence in the aesthetic dermatology market while leveraging AI technologies.
Read more →-SBC
May 1, 2026SBC Medical to Announce 1Q 2026 Financial Results
SBC Medical Group Holdings Incorporated will announce its financial results for Q1 2026 on May 14, 2026, before the U.S. market opens. An earnings conference call will follow at 8:30 a.m. Eastern Time, allowing analysts and investors to engage in a Q&A session. The company is known for its diverse healthcare services and ongoing global expansion.
Read more →-SBC
Apr 27, 2026SBC Medical Announces Full-Scale Rollout of Aesthetic Healthcare-Focused Interpretation App "Talk Bridge" Across All Shonan Beauty Clinic Locations
SBC Medical announced the full rollout of its interpretation app, Talk Bridge, across all Shonan Beauty Clinic locations to enhance English-speaking customer support. The initiative includes launching an in-house interpretation center and establishing a Global Beauty Advisor role. These measures aim to improve service for the growing number of international visitors seeking aesthetic healthcare in Japan.
Read more →About SBC Medical Group Holdings Incorporated
Headquarters200 SPECTRUM CENTER DR., IRVINE, CA, 92618
BIOPHARMAWATCH ELITE PLUS
Trade the next SBC catalyst before the market reprices
Every FDA decision, PoA score, 13F move and dilution flag on this page, for 1,100+ biotech tickers. From $19/mo billed annually.
Cancel anytime